IL18 and macrophage activation syndrome: We compared the accuracy of serum biomarkers including neopterin, IL-18, CXCL9, and soluble tumor necrosis factor receptor type I (sTNF-RI) and II for the diagnosis of MAS complicating s-JIA (124).